Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2015-06-01

Clinical Trial Update: Standardized sTudy With Almotriptan in eaRly Treatment of Migraine

View source ↗

Summary

This entry notes a completed clinical trial assessing almotriptan for early treatment of migraine.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Axert (Almotriptan)

Snippet

Sponsor: Almirall, S.A. | Conditions: Migraine | Status: COMPLETED